Rebolj, Matejka
Rask, Johanne
van Ballegooijen, Marjolein
Kirschner, Benny
Rozemeijer, Kirsten
Bonde, Jesper
Rygaard, Carsten
Lynge, Elsebeth
Article History
Received: 20 April 2015
Revised: 10 August 2015
Accepted: 24 August 2015
First Online: 8 October 2015
Competing interests
: JR, MvB, and BK declare no conflict of interest. MR, JB, CR, and EL are undertaking a comparative study of new-generation HPV assays, involving collaboration with Roche, Genomica, Qiagen, and Hologic, and a self-sampling pilot involving collaboration with Genomica, BD, and Rovers. MR and her former employer received honoraria from Qiagen for lectures on her behalf. KR was invited by BD to present her work at an international conference, for which she received no honorarium. JB used to serve as a paid advisor to Roche, is a paid advisor to Genomica, and received honoraria from Hologic, Roche, Qiagen, Genomica, and BD Diagnostics for lectures. He is a principal investigator on studies funded by BD Diagnostics. CR served as an unpaid advisor to Roche. EL served as an unpaid advisor to Hologic and Norchip. Hvidovre Hospital holds a recompense agreement with Genomica on a KRAS/BRAF diagnostic system. None of the authors was compensated for their work on this project, holds stock, or received bonuses from any of the manufacturers.